Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HPV signatures may predict anal cancer risk a decade later

NCT ID NCT06522256

First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 19 times

Summary

This study follows up with 100 people who took part in the ANRS IPERGAY trial to see how HPV infections relate to anal cancer risk over 10 years. Researchers will use special tests to find HPV molecular signatures and check for high-grade lesions or cancer. The goal is to better understand which HPV types or changes lead to cancer, helping improve future screening and prevention.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Saint-Louis - SMIT

    RECRUITING

    Paris, 75010, France

    Contact Email: •••••@•••••

    Contact

  • Hôpital Tenon - SMIT

    RECRUITING

    Paris, 75020, France

    Contact

    Contact Email: •••••@•••••

  • Hôpital de la Croix Rousse - SMIT

    RECRUITING

    Lyon, 69004, France

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.